The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Avar-e LS
Sulfacetamide Sodium, Sulfur · SULFACETAMIDE SODIUM 100 mg/g; SULFUR 20 mg/g · Cream · Topical · Mission Pharmacal Company
NDC 00178-0465-04 · 10 TUBE in 1 CARTON / 4 g in 1 TUBE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for sulfacetamide sodium, sulfur (other) in the next 90 days
price up 35% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sulfacetamide Sodium, Sulfur (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Mission Pharmacal Company | SULFACETAMIDE SODIUM 100 mg/g; SULFUR 50 mg/g | Jul 15, 2026 | Sep 3, 2026 |
| BioComp Pharma, Inc. | SULFACETAMIDE SODIUM 100 mg/g; SULFUR 50 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Cintex Services, LLC | SULFUR 48 mg/g; SULFACETAMIDE SODIUM 98 mg/g | Aug 26, 2026 | Sep 2, 2026 |
| Eckson Labs LLC | SULFUR 48 mg/g; SULFACETAMIDE SODIUM 98 mg/g | Aug 26, 2026 | Sep 2, 2026 |
| KMM Pharmaceuticals, LLC | SULFACETAMIDE SODIUM 98 mg/g; SULFUR 48 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Mission Pharmacal Company | SULFACETAMIDE SODIUM 100 mg/g; SULFUR 20 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Cintex Services, LLC | SULFACETAMIDE SODIUM 98 mg/g; SULFUR 48 mg/g | Jul 15, 2026 | Aug 30, 2026 |
| Cintex Services, LLC | SULFUR 98 mg/g; SULFACETAMIDE SODIUM 48 mg/g | Jul 22, 2026 | Aug 19, 2026 |
| Eckson Labs LLC | SULFUR 98 mg/g; SULFACETAMIDE SODIUM 48 mg/g | Jul 22, 2026 | Aug 19, 2026 |
| Eckson Labs LLC | SULFACETAMIDE SODIUM 98 mg/g; SULFUR 48 mg/g | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Avar-e LS — NDC 00178-0465-04," retrieved September 3, 2026, https://drugdashboards.com/drug/00178046504.
Free to cite with attribution — see how the data is put together.